Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases

Plain-language summary

This study aims to identify the disease-causing mechanisms and biomarkers in neurodegenerative diseases using omics-science methods. It enrolls patients who have a neurodegenerative disease. It is a study with no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Ospedale Policlinico San Martino

Start date

2/28/2025

Estimated completion

9/17/2039

Countries

Italy

Related genes

Locations

• Genoa, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria

• Patients suffering from neurodegenerative diseases

Exclusion Criteria

• Patients not suffering from neurodegenerative diseases